References
- Aslam S, Courtwright AM, Koval C, et al. Early clinical experience of bacteriophage therapy in 3 lung transplant recipients. AJTMBR. 2019 Sep;19(9):2631–2639. DOI:https://doi.org/10.1111/ajt.15503. PubMed PMID: 31207123; PubMed Central PMCID: PMCPMC6711787. eng.
- Maddocks S, Fabijan AP, Ho J, et al. Bacteriophage therapy of ventilator-associated pneumonia and empyema caused by pseudomonas aeruginosa. Am J Respir Crit Care Med. 2019 Nov 1;200(9):1179–1181. DOI:https://doi.org/10.1164/rccm.201904-0839LE. PubMed PMID: 31437402; eng.
- Dedrick RM, Guerrero-Bustamante CA, Garlena RA, et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant mycobacterium abscessus. Nat Med. 2019 May;25(5):730–733. DOI:https://doi.org/10.1038/s41591-019-0437-z. PubMed PMID: 31068712; PubMed Central PMCID: PMCPMC6557439. eng.
- Verroken A, Scohy A, Gerard L, et al. Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis. Crit Care. 2020 Jul 9;24(1):410), DOI:https://doi.org/10.1186/s13054-020-03135-7. PubMed PMID: 32646494; PubMed Central PMCID: PMCPMC7347259.
- Zhang H, Zhang Y, Wu J, et al. Risks and features of secondary infections in severe and critical ill COVID-19 patients. Emerg Microbes Infect. 2020 Dec;9(1):1958–1964. DOI:https://doi.org/10.1080/22221751.2020.1812437. PubMed PMID: 32815458.
- Bengoechea JA, Bamford CGG. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19? EMBO Mol Med. 2020 May 26. DOI:https://doi.org/10.15252/emmm.202012560. PubMed PMID: 32453917.
- WHO. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics, 2017 Feb 27. Available from: https://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/.
- Tan D, Zhang Y, Qin J, et al. A frameshift mutation in wcaJ associated with phage resistance in Klebsiella pneumoniae. Microorganisms. 2020 Mar 7;8(3). DOI:https://doi.org/10.3390/microorganisms8030378. PubMed PMID: 32156053; PubMed Central PMCID: PMCPMC7142929.
- Qin J, Wu N, Bao J, et al. Heterogeneous Klebsiella pneumoniae co-infections complicate personalized bacteriophage therapy. Front Cell Infect Microbiol. 2020;10(608402). DOI: https://doi.org/10.3389/fcimb.2020.608402. PubMed PMID: 33569355; PubMed Central PMCID: PMCPMC7868542. eng.
- Physicians RCo. National Early Warning Score (NEWS) 2: standardising the assessment of acute-illness severity in the NHS. Updated report of a working party. London: RCP 2017. Available from: https://www.rcplondon.ac.uk/projects/outputs/national-early-warning-score-news-2.
- Schooley RT, Biswas B, Gill JJ, et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob Agents Chemother. 2017 Oct;61(10). DOI:https://doi.org/10.1128/aac.00954-17. PubMed PMID: 28807909; PubMed Central PMCID: PMCPMC5610518. eng.
- Burmeister AR, Fortier A, Roush C, et al. Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance. Proc Natl Acad Sci U S A. 2020 May 26;117(21):11207–11216. DOI:https://doi.org/10.1073/pnas.1919888117. PubMed PMID: 32424102; PubMed Central PMCID: PMCPMC7260982.
- Leung CYJ, Weitz JS. Modeling the synergistic elimination of bacteria by phage and the innate immune system. J Theor Biol. 2017 Sep 21;429:241–252. DOI:https://doi.org/10.1016/j.jtbi.2017.06.037. PubMed PMID: 28668337; eng.
- Lin YW, Chang RY, Rao GG, et al. Pharmacokinetics/pharmacodynamics of antipseudomonal bacteriophage therapy in rats: a proof-of-concept study. Clin Microbiol Infect. 2020 Sep;26(9):1229–1235. DOI:https://doi.org/10.1016/j.cmi.2020.04.039. PubMed PMID: 32387436; eng.
- Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. 2020;8(4):420-422. DOI:https://doi.org/10.1016/s2213-2600(20)30076-x. PubMed PMID: 32085846.
- Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan. China. 2020;180(7):934–943. DOI:https://doi.org/10.1001/jamainternmed.2020.0994. PubMed PMID: 32167524.
- Tang S, Orsi RH, Luo H, et al. Assessment and comparison of molecular subtyping and characterization methods for salmonella. Front Microbiol. 2019;10:1591), DOI:https://doi.org/10.3389/fmicb.2019.01591. PubMed PMID: 31354679; PubMed Central PMCID: PMCPMC6639432.
- Dufour N, Delattre R, Chevallereau A, et al. Phage therapy of pneumonia is not associated with an overstimulation of the inflammatory response compared to antibiotic treatment in mice. Antimicrob Agents Chemother. 2019 Aug;63(8). DOI:https://doi.org/10.1128/AAC.00379-19. PubMed PMID: 31182526; PubMed Central PMCID: PMCPMC6658787.
- Dufour N, Delattre R, Ricard JD, et al. The lysis of pathogenic Escherichia coli by bacteriophages releases less Endotoxin than by beta-Lactams. Clin Infect Dis. 2017 Jun 1;64(11):1582–1588. DOI:https://doi.org/10.1093/cid/cix184. PubMed PMID: 28329379; PubMed Central PMCID: PMCPMC5434335.
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054–1062. DOI:https://doi.org/10.1016/S0140-6736(20)30566-3. PubMed PMID: 32171076.
- Tisoncik JR, Korth MJ, Simmons CP, et al. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2012 Mar;76(1):16–32. DOI:https://doi.org/10.1128/MMBR.05015-11. PubMed PMID: 22390970; PubMed Central PMCID: PMCPMC3294426.